Patients With Stage 4 GISTs Maintain Notable Survival Rates at 5 Years, Analysis Finds
Stage 4 gastrointestinal stromal tumors were analyzed through a database query, results of which were presented in a poster at a recent medical meeting.
Diabetes Risk Reduction Diet Adherence Improved Survival for Patients with Breast Cancer
Adhering to a diabetes risk reduction diet improved survival for women with stage 1 to 3 breast cancer compared to women who did not follow this specific diet.
Venetoclax and Rituximab Sustains Survival Benefit After 5 Years
Treatment with the combination regimen improved progression-free survival (PFS) and overall survival (OS) over a 5-year period compared with patients treated with bendamustine and rituximab.